Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.

Baxronova Yulduzxon, Raximova Matluba, Buranova Sagdiana,

dc.contributor.author	Baxronova Yulduzxon, Raximova Matluba, Buranova Sagdiana,
dc.date.accessioned	2023-02-20T05:44:05Z
dc.date.available	2023-02-20T05:44:05Z
dc.date.issued	2023
dc.identifier.citation	Toshkent	en_US
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6382
dc.description.abstract	In the article, the scientific literature confirming the effect of spirinolactone and eplerenone, belonging to the group of mineralocorticoid receptor antagonists, on the quality of life, the number of hospitalizations, the outcome of the disease, and the length of life of patients with chronic heart failure was studied, and the effects of these two drugs were comparatively evaluated.	en_US
dc.language.iso	en	en_US
dc.subject	Aldosterone, mineralocorticoid receptor antagonists, veroshpiron, eplerenone	en_US
dc.title	Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.	en_US
dc.type	Thesis	en_US